Fiebre reumática aguda

1. Rwebembera J, Nascimento BR, Minja NW, et al. Recent advances in the rheumatic fever and rheumatic heart disease continuum. Pathogens 2022;11:179.

2. Wyber R, Noonan K, Halkon C, et al. Ending rheumatic heart disease in Australia: the evidence for a new approach. Med J Aust 2020;213:S3–S31.

3. Katzenellenbogen JM, Bond-Smith D, Seth RJ, et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J Am Heart Assoc 2020;9:e016851.

4. Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015;131:1806–1818.

5. Ralph AP, Webb R, Moreland NJ, et al. Searching for a technology-driven acute rheumatic fever test: the START study protocol. BMJ Open 2021;11:e053720.

6. Francis JR, Whalley GA, Kaethner A, et al. Singleview echocardiography by nonexpert practitioners to detect rheumatic heart disease: a prospective study of diagnostic accuracy. Circulation: Cardiovasc Imaging 2021;14:e011790.

7. Yılmaz M, Gürses D, Sabırlı G. The effectiveness and safety of ibuprofen and acetylsalicylic acid in acute rheumatic fever. Pediatr Int 2022;64:e15133.

8. Cilliers A, Adler AJ, Saloojee H. Antiinflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev 2015;5:CD003176.

9. Teixeira AL, Vasconcelos LP, Nunes MCP, et al. Sydenham’s chorea: from pathophysiology to therapeutics. Expert Rev Neurother 2021;21:913– 922.